NTRK alterations in pediatric high-risk malignancies identified through European clinical sequencing programs constitute promising drug targets

Saved in:

Bibliographic Details
Main Authors:	Pfaff, Elke (Author) , Adam de Beaumais, Tiphaine (Author) , Marchais, Antonin (Author) , Tilburg, Cornelis M. van (Author) , Blattner-Johnson, Mirjam (Author) , Dirksen, Uta (Author) , Øra, Ingrid (Author) , Geoerger, Birgit (Author) , Schleiermacher, Gudrun (Author) , Pfister, Stefan (Author) , Witt, Olaf (Author) , Jones, David T. W. (Author) , Vassal, Gilles (Author)
Format:	Article (Journal) Editorial
Language:	English
Published:	February 26, 2021
In:	JCO precision oncology Year: 2021, Volume: 5, Pages: 450-454
ISSN:	2473-4284
DOI:	10.1200/PO.20.00417
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/PO.20.00417 Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/10.1200/PO.20.00417
Author Notes:	Elke Pfaff, Tiphaine Adam de Beaumais, Antonin Marchais, Cornelis M. van Tilburg, Mirjam Blattner-Johnson, Uta Dirksen, Ingrid Øra, Birgit Geoerger, Gudrun Schleiermacher, Stefan M. Pfister, Olaf Witt, David T.W. Jones, Gilles Vassal

Similar Items